These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32281762)

  • 1. [Screening and management of HCV-positive CKD outpatients].
    Gernone G; Detomaso F; Partipilo F; Gernone S
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281762
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.
    Manoj Kumar ; Nayak SL; Gupta E; Kataria A; Sarin SK
    Liver Int; 2018 Dec; 38(12):2137-2148. PubMed ID: 29676846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Direct-acting antiviral agents, hepatitis C and dialysis: an update].
    Fabrizi F; Lampertico P; Messa P
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.
    Fabrizi F; Donato FM; Messa P
    Int J Artif Organs; 2017 Oct; 40(10):531-541. PubMed ID: 28708211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease.
    Morisawa N; Koshima Y; Satoh JI; Maruyama Y; Kuriyama S; Yokoo T; Amemiya M
    Clin Exp Nephrol; 2017 Oct; 21(5):818-824. PubMed ID: 27771774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
    Mendizabal M; Reddy KR
    J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
    Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
    J Nephrol; 2018 Oct; 31(5):685-712. PubMed ID: 30255440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
    Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
    J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
    Awan AA; Jadoul M; Martin P
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Hepatitis C in Patients with Renal Failure.
    Lens S; Rodriguez-Tajes S; Llovet LP; Maduell F; Londoño MC
    Dig Dis; 2017; 35(4):339-346. PubMed ID: 28467997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatitis C in patients with chronic kidney disease.
    Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
    World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations".
    Pol S; Parlati L
    Liver Int; 2018 Feb; 38 Suppl 1():28-33. PubMed ID: 29427485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in hepatitis C virus management in chronic kidney disease.
    Cohen-Bucay A; Francis JM; Gordon CE
    Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):493-500. PubMed ID: 34054074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
    Awan AAY; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Martin P; Jadoul M
    Ann Intern Med; 2023 Dec; 176(12):1648-1655. PubMed ID: 38079642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience.
    Muñoz-Gómez R; Rincón D; Ahumada A; Hernández E; Devesa MJ; Izquierdo S; Ortiz M; Hernández-Albujar A; Fernández-Rodríguez C; Calvo M; González R; Lozano M; Castellano G; Fernández-Vázquez I
    J Viral Hepat; 2017 Jun; 24(6):464-471. PubMed ID: 27976490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV treatment initiation in persons with chronic kidney disease in the directly acting antiviral agents era: Results from ERCHIVES.
    Butt AA; Ren Y; Puenpatom A; Arduino JM; Kumar R; Abou-Samra AB
    Liver Int; 2018 Aug; 38(8):1411-1417. PubMed ID: 29271562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
    Fabrizi F; Martin P; Messa P
    Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents.
    Elmowafy AY; El Maghrabi HM; Mashaly ME; Eldahshan KF; Rostaing L; Bakr MA
    Int Urol Nephrol; 2019 Dec; 51(12):2243-2254. PubMed ID: 31612423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.